Chargement en cours...
Acute myeloid leukemia: current progress and future directions
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhibitors, IDH inhibitors, and others. The manage...
Enregistré dans:
| Publié dans: | Blood Cancer J |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group UK
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900255/ https://ncbi.nlm.nih.gov/pubmed/33619261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00425-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|